Capecitabine 150mg Tablet, Film Coated
Product Images NDC 72485-204
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Capecitabine 150mg (NDC 72485-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Metabolic Pathway (Meta Pathway)
Figure 1 Kaplan-meier Estimates Of Disease-free Survival (all Randomized Population)a (Fig 1)
Figure 2 Kaplan-meier Estimates Of Overall Survival (all Randomized Population) (Fig 2)
Figure 3 Kaplan-meier Curve For Overall Survival Of Pooled Data (studies 1 And 2) (Fig 3)
Figure 4 Kaplan-meier Estimates For Time To Disease Progression Capecitabine And Docetaxel Vs Docetaxel (Fig 4)
Figure 5 Kaplan-meier Estimates Of Survival Capecitabine And Docetaxel Vs Docetaxel (Fig 5)
Image Description (72485204 2)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.